is glp 3rt retatrutide GLP-3 RT (LY3437943) Peptide Retatrutide peptide for weight loss

or uncontrolled high blood pressure despite ongoing treatment with two hypertension medications

Pyke C, Heller RS, Kirk RK, Orskov C, Reedtz-Runge S, Kaastrup P, Hvelplund A, Bardram L, Calatayud D, Knudsen LB

HR: 0.50, 95% CI: 0.390.63) compared to patients not treated with GLP-1 medications ( n = 26,566) over 12 months, findings consistent across gender, age, race, and presence or absence of T2D

NativePath the caloric restriction and appetite suppression that GLP-1 medications produce may affect structural tissue too - specifically bone mineral density and lean mass

Both medications also carry a serious warning about a potential risk of thyroid tumors, including medullary thyroid carcinoma, based on studies in animals

It also helps maintain lean body mass during GLP-1 treatment